Neurosense Therapeutics Ltd
NRSNW
View Detailed Chart
0.350USD
0.0000.00%
Market hours （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
+25.00%
1 Month
-10.21%
6 Months
-60.67%
Year to Date
+12.90%
1 Year
0.00%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Neurosense Therapeutics Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Neurosense Therapeutics Ltd Info
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Ticker SymbolNRSNW
CompanyNeurosense Therapeutics Ltd
CEOMr. Alon Ben-Noon
Websitehttps://www.neurosense-tx.com/
Popular Symbols
259.890
+4.480 (+1.75%)
186.702
+0.232 (+0.12%)
89100.010
+1500.790 (+1.71%)
245.160
+4.310 (+1.79%)
3009.330
+110.010 (+3.79%)
435.750
+0.550 (+0.13%)
5138.180
+83.290 (+1.65%)
62.191
+1.500 (+2.47%)
1.199
+0.011 (+0.90%)
152.590
-1.493 (-0.97%)
